Market Overview

Semiconductors are staging a recovery rally after last week’s sharp selloff, lifting Nasdaq futures +0.4% pre-bell. The macro backdrop remains tense with US-Iran tensions pushing crude above $83/bbl, but strong earnings from 3M and GM are providing a confidence boost. Memory chip names (MU, SNDK) are the focal point as GM’s guidance flagged ongoing supply constraints in auto memory chips, validating demand narratives.

Claude’s Call

UP — Earnings beats from industrial bellwethers (MMM, GM) combined with the semiconductor bounce create enough positive momentum to push the S&P 500 modestly higher today, though gains will be capped by elevated oil prices and geopolitical overhang from the Iran situation.

Top Movers

UTZ (+89.1%) — $14.09 → $14.25 (+1.1% upside to deal price) Thesis: This is a take-private at $14.25/share cash — the 91% premium from Intersnack is the entire story. The stock is trading at $14.09, just 16 cents below the deal price, which implies the market sees >95% close probability. There’s nothing to trade here unless you’re an M&A arb specialist picking up pennies. The deal is valued at $2.9B including debt, representing a ~14x EBITDA multiple for a struggling snack brand — generous pricing that suggests this closes. Levels: Ceiling at $14.25 (deal price). Floor at $13.50 if deal-break fears emerge.

MMM (+9.7%) — $175.51 → $185.00 (+5.4% upside) Thesis: Classic turnaround earnings beat — adjusted EPS of $2.40 beat consensus, and full-year guidance was raised. The “new 3M” narrative under restructured operations is gaining traction as AI-accelerated product launches and noncore asset divestitures show up in margins. This isn’t a dead-cat bounce; it’s the second consecutive quarter of operational improvement. Stock is breaking out of a multi-month consolidation, and the raised guidance gives fundamental support for higher prices. Levels: Exit at $185 (prior resistance zone from early 2026). Support at $165 (pre-earnings breakout level).

COIN (+9.6%) — $176.48 → $195.00 (+10.5% upside) Thesis: Dual catalyst — the Clarity Act crypto regulation bill is nearing a Senate vote (Trump agreed to ethics provisions), and Morgan Stanley’s E*Trade launching crypto trading validates the institutional adoption thesis. COIN was beaten down 65% over the past year, and regulatory clarity is the single biggest overhang removal possible. The “crypto bottom” call from a top investment firm adds fuel. This has room to run if the Clarity Act passes, but beware — these legislative catalysts have a history of “sell the news.” Levels: Exit at $195 (50-day MA likely overhead resistance). Support at $160 (prior session’s close).

GM (+4.4%) — $79.37 → $85.00 (+7.1% upside) Thesis: GM raised full-year 2026 guidance by $500M — the second raise this year — driven by lower tariffs, better margins, and reduced EV losses. Management flagged memory chip supply constraints (bullish read-through for MU/SNDK). The RSI at 1.48 is absurdly oversold, suggesting this stock was heavily shorted or neglected headed into the print. The earnings beat + double guidance raise on a deeply oversold name is textbook buy-the-dip. Levels: Exit at $85 (round number resistance, pre-selloff support). Support at $76 (today’s gap-fill level).

CIFR (+6.0%) — $21.89 → $25.00 (+14.2% upside) Thesis: Morgan Stanley just put a $76 bull case on this name, citing AI infrastructure value of former mining campuses with existing grid connections. The stock bounced 17% yesterday off a 3-month low of $16.13, and this is continuation of that recovery. The AI data center pivot via long-term lease agreements is the secular story, but near-term this is a beaten-down bounce trade ahead of Q2 earnings. RSI at 0.39 indicates extreme oversold conditions — the snapback potential is significant. Levels: Exit at $25 (mid-range resistance before July selloff). Support at $18.50 (yesterday’s consolidation zone).

LASR (+8.7%) — $72.92 → $78.00 (+7.0% upside) Thesis: This is riding the $627M Department of Defense Joint Laser Weapon System contract from July 9. The defense spending tailwind is real and multi-year, but after a 387% three-year run, analysts are flagging the stock as “fully priced.” Today’s 8.7% pop on no new news suggests momentum chasers piling in. The defense contract is legitimate, but at these levels you’re paying for perfection on execution over years. Be cautious chasing. Levels: Exit at $78 (round number, likely short-term resistance). Support at $67 (last week’s close area).

IOVA (+6.0%) — $5.31 → $6.50 (+22.4% upside) Thesis: A speculative biotech bounce — up 35% on the week after a regulatory nod expanded its TIL cell therapy into new indications. At $5.31 this is penny stock territory for a company that’s treated 1,500+ patients. The 74% YTD run was followed by a pullback, and this appears to be a resumption. High risk/high reward — pipeline catalysts could drive another leg up, but biotech at $5 can go to zero just as easily. Levels: Exit at $6.50 (prior resistance from June rally). Support at $4.40 (June low).

Headlines to Watch

  • Clarity Act Nears Senate Vote — If crypto regulation passes, COIN and other digital asset stocks could see 10-15% moves; failure means the rally reverses hard.
  • Morgan Stanley E*Trade Launches Crypto Trading — Institutional adoption milestone that legitimizes crypto for retail brokerage clients; structurally bullish for exchange volumes.
  • GM Flags Memory Chip Constraints — Validates MU and SNDK demand thesis and explains why WSB is piling into these names; supply shortage = pricing power.
  • 3M Raises Full-Year Guidance — Industrial bellwether signaling the economy is stronger than feared; positive read-through for broader industrials.
  • US-Iran Tensions Push Oil to $83+ — Risk-off catalyst lurking in the background; if crude breaks $90, expect consumer discretionary pain and defensive rotation.
  • Morgan Stanley $76 Bull Case on CIFR — Reframes bitcoin miners as AI infrastructure plays; could trigger sector-wide re-rating if thesis gains traction.
  • Intersnack Takes UTZ Private at 91% Premium — Signals European strategic buyers see value in beaten-down US consumer brands; watch for M&A activity in adjacent names.

Claude’s Top Picks

GM (+4.4% today, +3.3% week) — $79.37 → $85.00 (+7.1% upside) Valuation: At ~5.5x forward P/E with a double guidance raise, GM is absurdly cheap relative to industrial peers trading at 12-15x; even vs. Ford at ~7x, GM’s execution warrants a premium. Upside: Second guidance raise in 2026 with RSI at 1.48 (extreme oversold) means institutional re-rating has barely begun; the memory chip constraint narrative also makes it a sympathy play for the hottest sector. Risk: Oil above $85/bbl would crush auto demand expectations, and tariff policy could reverse the margin tailwinds management cited.

COIN (+9.6% today, +9.3% week) — $176.48 → $195.00 (+10.5% upside) Valuation: Down 65% from highs, COIN trades at a fraction of its peak multiple; if Clarity Act passes, re-rating toward 2024 multiples implies significant upside. Upside: Legislative catalyst (Clarity Act vote this week) + institutional adoption (E*Trade) is a one-two punch that could compress the regulatory discount in days. Risk: “Sell the news” on Clarity Act passage, or a crypto market downturn that crushes trading volumes — COIN’s revenue is still heavily transaction-dependent.

MMM (+9.7% today, +12.1% week) — $175.51 → $185.00 (+5.4% upside) Valuation: Trading at ~17x forward earnings post-guidance raise; for a restructuring story re-accelerating growth with AI-driven product launches, this is fair-to-cheap vs. industrial peers at 18-22x. Upside: Turnaround narrative gaining institutional credibility; raised guidance provides a new floor for estimates, and the stock just triggered a buy signal with early entry breakout. Risk: One-time items or legal overhang from legacy liabilities could resurface; turnarounds frequently have setbacks.

CIFR (+6.0% today, +10.2% week) — $21.89 → $25.00 (+14.2% upside) Valuation: Expensive on trailing metrics (296% 3-year return), but Morgan Stanley’s $76 bull case prices the AI infrastructure pivot that isn’t yet reflected in consensus models. Upside: Extreme oversold RSI (0.39) bouncing off 3-month lows with a major bank bull case = classic snapback setup ahead of Q2 earnings. Risk: If earnings disappoint or AI lease revenue fails to materialize, the “overvalued” narrative reasserts and the stock revisits $16.

BRBR (+5.5% today, +4.1% week) — $12.60 → $14.00 (+11.1% upside) Valuation: After a 79% decline over 12 months, BRBR screens as deeply cheap on both P/E and EV/EBITDA vs. consumer packaged goods peers; new CEO catalyst could re-rate sentiment. Upside: Leadership change (Michael Axelrod starts July 29) is a clean reset narrative; protein category remains a secular growth tailwind despite company-specific execution issues. Risk: The stock declined 79% for a reason — if the new CEO doesn’t articulate a clear strategic vision quickly, value traps can stay trapped.

Avoid

UTZ (+89.1%) — Take-private deal at $14.25/share means there’s only $0.16 of upside remaining. You’re picking up pennies in front of a steamroller with deal-break risk providing all the downside. Zero edge here for swing traders.

LASR (+8.7%) — After a 387% three-year run with analysts calling it “fully priced,” today’s pop came on zero new news — pure momentum chasing. The defense contract is priced in, and any execution miss on the multi-year JLWS program sends this down 20%+ fast.

IOVA (+6.0%, +35% week) — Penny stock biotech trading at $5.31 with a 35% weekly gain is the definition of chasing. Binary event risk from pipeline data means this could halve overnight. The upside is real but so is the potential for total loss — not appropriate for a disciplined swing trade.

WSB Sentiment Check

MU — WSB says: BULLISH (80% bullish) Claude says: AGREE — GM’s earnings call specifically flagged memory chip supply constraints, validating the demand thesis. The semiconductor recovery rally today puts MU in the sweet spot of fundamental + technical tailwinds. This is one of the rare times WSB is actually early rather than late.

SPCX — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY — This is a crypto/blockchain ETF benefiting from the Clarity Act legislative catalyst. The setup is real near-term, but ETFs don’t squeeze and the regulatory catalyst is binary — if the vote fails, this reverses. Smart to be long ahead of the vote, but size accordingly.

MSFT — WSB says: BULLISH (80% bullish) Claude says: AGREE — Big tech earnings are this week, and MSFT’s AI narrative (Copilot, Azure) remains intact. The chip recovery today benefits the entire AI stack. This is the boring-but-correct trade heading into earnings; MSFT rarely disappoints catastrophically.

NVDA — WSB says: BULLISH (80% bullish) Claude says: AGREE — Semiconductor bounce after last week’s selloff, AI demand narrative intact, and the memory chip supply constraint story reinforces GPU ecosystem demand. The question isn’t direction but timing — NVDA tends to rally into earnings (not reporting this week) but the Iran overhang could cap upside.

SNDK — WSB says: BULLISH (80% bullish) Claude says: AGREE — A $170K→$1M YTD return makes this the poster child of the memory chip cycle. GM’s supply constraint commentary and Nomura saying “AI memory demand concerns are overdone” both support the bull case. However, after this kind of run, position sizing matters more than direction — any negative data point triggers a violent correction.

Earnings Scorecard

DPZ — REPORTED | Stock: +0.3% | Details: N/A The flat reaction suggests an in-line quarter with no major surprises in either direction. With no EPS data available, the muted move tells us the market had already priced in current trends. Neither a buy nor a sell signal — this is a hold until we see the actual numbers and guidance details. Move along.

MMM — BEAT | Stock: +9.7% | Reported: Tuesday Before Open Adjusted EPS of $2.40 beat consensus with full-year guidance raised. The 9.7% reaction is justified — this is a turnaround story with accelerating momentum, and the guidance raise provides air cover for further re-rating. Buy remaining weakness; the new floor is the pre-earnings price around $160.

GM — BEAT | Stock: +4.4% | Reported: Tuesday Before Open Revenue, adjusted EPS, and free cash flow all beat with full-year guidance raised by $500M (second raise this year). The 4.4% reaction feels INSUFFICIENT given the quality of the beat and the deeply oversold starting point (RSI 1.48). This suggests lingering macro skepticism (tariffs, oil) that should fade as the numbers speak. Buy-the-dip opportunity if it pulls back intraday.